- Dr AG Jeetoo Hospital (Civil)
Port Louis, Mauritius - Mon - Sat 8.00 - 18.00.
Sunday CLOSED
News & Events
- 24th July 2023
Gilead Visit
In January 2020, a significant milestone was achieved in Mauritius's healthcare landscape when Prime Minister Honorable Pravin Jugnauth signed an agreement with Gilead Sciences. This agreement secured a donation of the state-of-the-art drug EPCLUSA, capable of treating over 98% of Hepatitis C patients in just three months. Unlike previous treatments, EPCLUSA is pan-genotypic, meaning it can cure patients regardless of their specific genotype, streamlining treatment pathways and minimizing side effects.
The donation, valued at Rs 3 billion, marked a monumental step forward in patient care, especially considering Mauritius's annual healthcare budget of approximately Rs 11 billion. With significant investment from the Ministry of Health and Wellness, a National Hepatitis C Elimination Programme was structured, radically transforming the landscape of Hepatitis C treatment in Mauritius.
This initiative propelled Mauritius into the ranks of the top 10 countries in Africa for Hepatitis C treatment, positioning the nation on track for Hepatitis C Elimination by 2030.
A testament to this success was Gilead Sciences' official visit in July 2023, acknowledging the impactful collaboration between the industry and government.
Led by Mr. Neil Mulcock, Senior Vice-President, and Mr. Dustin Haines, Senior Vice-President of Gilead, the visit celebrated the positive impact on the lives of over 2000 patients and laid the groundwork for further enhancements through a national programme.
